340 related articles for article (PubMed ID: 28606846)
1. Agreement Between Home-Based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity.
Heida A; Knol M; Kobold AM; Bootsman J; Dijkstra G; van Rheenen PF
Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1742-1749.e2. PubMed ID: 28606846
[TBL] [Abstract][Full Text] [Related]
2. Head-to-head comparison of three stool calprotectin tests for home use.
Haisma SM; Galaurchi A; Almahwzi S; Adekanmi Balogun JA; Muller Kobold AC; van Rheenen PF
PLoS One; 2019; 14(4):e0214751. PubMed ID: 30998692
[TBL] [Abstract][Full Text] [Related]
3. IBDoc Canadian User Performance Evaluation.
Moore AC; Huang VW; Bourdages R; Fedorak RN; Reinhard C; Leung Y; Bressler B; Rosenfeld G
Inflamm Bowel Dis; 2019 May; 25(6):1107-1114. PubMed ID: 30535387
[TBL] [Abstract][Full Text] [Related]
4. Faecal calprotectin: comparative study of the Quantum Blue rapid test and an established ELISA method.
Coorevits L; Baert FJ; Vanpoucke HJ
Clin Chem Lab Med; 2013 Apr; 51(4):825-31. PubMed ID: 23001318
[TBL] [Abstract][Full Text] [Related]
5. Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome.
Sydora MJ; Sydora BC; Fedorak RN
J Crohns Colitis; 2012 Mar; 6(2):207-14. PubMed ID: 22325175
[TBL] [Abstract][Full Text] [Related]
6. Fecal calprotectin levels in children is more tightly associated with histological than with macroscopic endoscopy findings.
Hradsky O; Ohem J; Mitrova K; Durilova M; Kotalova R; Nevoral J; Kolho KL; Bronsky J
Clin Lab; 2014; 60(12):1993-2000. PubMed ID: 25651733
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Liaison® Calprotectin kit with a well established point of care test (Quantum Blue - Bühlmann-Alere®) in terms of analytical performances and ability to detect relapses amongst a Crohn population in follow-up.
Delefortrie Q; Schatt P; Grimmelprez A; Gohy P; Deltour D; Collard G; Vankerkhoven P
Clin Biochem; 2016 Feb; 49(3):268-73. PubMed ID: 26506117
[TBL] [Abstract][Full Text] [Related]
8. [Calprotectin levels in patients with idiopathic inflammatory bowel disease comparison of two commercial tests].
Malícková K; Janatková I; Bortlík M; Komárek V; Lukás M
Epidemiol Mikrobiol Imunol; 2008 Nov; 57(4):147-53. PubMed ID: 19069028
[TBL] [Abstract][Full Text] [Related]
9. The Accuracy of a Home-performed Faecal Calprotectin Test in Paediatric Patients With Inflammatory Bowel Disease.
Lerchova T; Hradsky O; Copova I; Potuznikova K; Gonsorcikova L; Bronsky J
J Pediatr Gastroenterol Nutr; 2019 Jul; 69(1):75-81. PubMed ID: 30908389
[TBL] [Abstract][Full Text] [Related]
10. Measurement of calprotectin in ascitic fluid to identify elevated polymorphonuclear cell count.
Burri E; Schulte F; Muser J; Meier R; Beglinger C
World J Gastroenterol; 2013 Apr; 19(13):2028-36. PubMed ID: 23599621
[TBL] [Abstract][Full Text] [Related]
11. Fecal Calprotectin Test Performed at Home: A Prospective Study of Pediatric Patients With Inflammatory Bowel Disease.
Piekkala M; Alfthan H; Merras-Salmio L; Puustinen Wikström A; Heiskanen K; Jaakkola T; Klemetti P; Färkkilä M; Kolho KL
J Pediatr Gastroenterol Nutr; 2018 Jun; 66(6):926-931. PubMed ID: 29240011
[TBL] [Abstract][Full Text] [Related]
12. Validation of Two Calprotectin Rapid Tests in Daily Routine.
Schulz C; Wex T; Arnim UV; Malfertheiner P
Clin Lab; 2016 Jul; 62(7):1249-1254. PubMed ID: 28164652
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Quantum Blue® rapid test for faecal calprotectin.
Wassell J; Wallage M; Brewer E
Ann Clin Biochem; 2012 Jan; 49(Pt 1):55-8. PubMed ID: 21930735
[TBL] [Abstract][Full Text] [Related]
14. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
[TBL] [Abstract][Full Text] [Related]
15. Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure.
Kristensen V; Malmstrøm GH; Skar V; Røseth A; Moum B
Scand J Gastroenterol; 2016; 51(5):548-55. PubMed ID: 26634305
[TBL] [Abstract][Full Text] [Related]
16. Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease.
De Sloovere MMW; De Smet D; Baert FJ; Debrabandere J; Vanpoucke HJM
Clin Chem Lab Med; 2017 Aug; 55(9):1435-1446. PubMed ID: 28076305
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.
Oyaert M; Trouvé C; Baert F; De Smet D; Langlois M; Vanpoucke H
Clin Chem Lab Med; 2014 Mar; 52(3):391-7. PubMed ID: 24114912
[TBL] [Abstract][Full Text] [Related]
18. The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity.
Lee YW; Lee KM; Lee JM; Chung YY; Kim DB; Kim YJ; Chung WC; Paik CN
Korean J Intern Med; 2019 Jan; 34(1):72-80. PubMed ID: 29347813
[TBL] [Abstract][Full Text] [Related]
19. Analytical evaluation of a fully automated immunoassay for faecal calprotectin in a paediatric setting.
Noebauer B; Ramic L; Konstantin A; Zachbauer C; Einwallner E
Biochem Med (Zagreb); 2017 Oct; 27(3):030710. PubMed ID: 29180918
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a fluorescent immunochromatography test for fecal calprotectin.
Li R; Zhao X; Dong J; Zhu D; Wang T; Yang S; Zhao Z; Xiao N
J Clin Lab Anal; 2020 Feb; 34(2):e23059. PubMed ID: 31587371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
